Publicação científica trimestral do CREMERJ - volume 2 - número 2 - 2023

54 Esteatose Pancreática José Galvão-Alves e Bruna Cerbino de Souza Med. Ciên. e Arte , Rio de Janeiro, v.2, n.2, p.42-54, abr-jun 2023 40. Poitout V, Amyot J, Semache M et al. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 2010; 1801: 289-298. 41. Wang CY, Ou HY, Chen MF et al. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc 2014; 3: e000297. 42. Della Corte C, Mosca A, Majo F et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf) 2015; 83: 656-662. 43. Saisho Y, Butler AE, Meier JJ et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20: 933-942. 44. van der Zijl NJ, Goossens GH, Moors CC et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab. 2011;96:459-467. 45. Dupont C. et al. Pancreatic lipomatosis and duodenal stenosis or atresia in children. J. Pediatr. 115, 603- 605 (1989). 46. Lozano M. et al. Lipomatosis of the pancreas: an unusual cause of massive steatorrhea. Pancreas 3, 580- 582 (1988). 47. Midiri M et al. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. AJR Am. J. Roentgenol. 173, 187-192 (1999). 48. So CB, Cooperberg PL, Gibney RG & Bogoch A. Sonographic findings in pancreatic lipomatosis. AJR Am. J. Roentgenol. 149, 67-68 (1987). 49. Aubert A et al. Diffuse primary fat replacement of the pancreas: an unusual cause of steatorrhea [French]. Gastroenterol. Clin. Biol. 31, 303-306 (2007). 50. Khatua B, El-Kurdi B, Singh V. Obesity and pancreatitis. Curr Opin Gastroenterol, 33:000-000 (2017). 51. Taguchi M, Kubo T, Yamamoto M et al. Body mass index influences the outcome of acute pancreatitis: an analysis based on the Japanese administrative database. Pancreas. 2014;43:863-866. 52. Zyromski NJ, Mathur A, Pitt HA et al. A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2008;295:G552-558. 53. Stolzenberg-Solomon RZ, Adams K, Leitzmann M et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586-597. 54. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301-316. 55. Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7:e330-341. 56. Hori M, Takahashi M, Hiraoka N et al. Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 2014;5:e53. 57. Mathur A, Zyromski NJ, Pitt HA et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208:989-994. (discussion 994-986). 58. Yang DM, Kim HC, Ryu JK, Joo KR & Ahn KJ. Sonographic appearance of focal fatty infiltration of the pancreas. J. Clin. Ultrasound 38, 45-47 (2010). 59. Mathur A et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann. Surg. 246, 1058-1064 (2007). 60. Gaujoux S et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 148, 15-23 (2010). 61. Lee SE et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann. Surg. 251, 932-936 (2010). 62. Rosso E. et al. The role of “fatty pancreas” and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J. Gastrointest. Surg. 13, 1845-1851 (2009).